FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New guidelines for radiation therapy for HPV-associated head and neck cancer

2.

Cancer mortality continuing to decline, says report

3.

Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation

4.

There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.

5.

Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot